Celera Genomics, Exelixis Incorporated, and Clontech Laboratories Subscribe To the TRANSFAC(R) Professional Database by BIOBASE GmbH

Subscriptions Validate TRANSFAC(R) Professional's Relevance to a Wide Array

Of Researchers



Apr 18, 2001, 01:00 ET from Cognia Corporation

    MOUNTAIN VIEW, Calif., April 18 /PRNewswire/ -- BIOBASE Biological
 Databases GmbH and its exclusive North American distribution partner, Cognia,
 announced today that Celera Genomics, Clontech Laboratories, and Exelixis have
 joined the numerous pharmaceutical and biotech organizations who already
 subscribe to the TRANSFAC(R) Professional database, the premier database for
 the analysis of transcription factors and transcriptional regulation.  The
 subscriptions will give these companies access to all information in
 TRANSFAC(R) Professional and associated analysis tools including MATCH(TM), a
 powerful new tool used to mine sequences for transcription factor binding
 sites.
     "Adding leading genomics and biotech research groups to Cognia's growing
 list of customers demonstrates that researchers in vastly different areas find
 value in and use our bioinformatics products," said David M. Rubin, Ph.D.,
 Cognia's President and CEO.  Holger Karas, CEO of BIOBASE added, "TRANSFAC(R)
 Professional may help these researchers accelerate their discovery processes
 by helping them understand and navigate more efficiently through their
 research data."
     The information contained in TRANSFAC(R) Professional spans a broad range
 of organisms, including plant, yeast, murine, and human systems.  Also
 included is information from the SNP Consortium enabling users of TRANSFAC(R)
 Professional to more easily use this genetic variance data in their research.
 The TRANSFAC(R) Professional database and associated search tools were created
 and continue to be annotated and curated by BIOBASE of Braunschweig, Germany.
 Cognia Corporation is a developer and distributor of knowledge based products
 that facilitate the use of genomic, proteomic and cellomic/physiological
 information.
 
     About BIOBASE Biological Databases GmbH
     BIOBASE is a world leading creator, annotator, and curator of biological
 databases.  Based in Braunschweig, Germany, BIOBASE develops databases and
 software aimed at analyzing transcription regulation, one of the fundamental
 mechanisms in biology.  BIOBASE is a private company and was established in
 1997 at the National Research Center for Biotechnology Ltd. (GBF).  BIOBASE
 offers worldwide a unique portfolio of databases including the TRANSFAC(R)
 database, the premier database on transcription factors, their genomic binding
 sites, and their general binding properties.
 
     About Cognia
     Cognia is a developer and distributor of knowledge-based products that
 facilitate the use of genomic, proteomic and cellomic/physiological
 information.  Cognia provides integrated suites of high-quality, annotated
 databases, cutting edge bioinformatics tools, and associated consulting and
 training services to accelerate drug discovery and basic research.  Cognia's
 products and services help pharmaceutical and biotechnology companies to
 efficiently and cost-effectively discover and develop new drugs, by
 accelerating research processes.  Cognia's customers include leading
 pharmaceutical and biotechnology companies such as SmithKline Beecham,
 Schering-Plough, Eli Lilly, Monsanto, Protein Pathways, Berlex Biosciences,
 and Scios.
 
 

SOURCE Cognia Corporation
    MOUNTAIN VIEW, Calif., April 18 /PRNewswire/ -- BIOBASE Biological
 Databases GmbH and its exclusive North American distribution partner, Cognia,
 announced today that Celera Genomics, Clontech Laboratories, and Exelixis have
 joined the numerous pharmaceutical and biotech organizations who already
 subscribe to the TRANSFAC(R) Professional database, the premier database for
 the analysis of transcription factors and transcriptional regulation.  The
 subscriptions will give these companies access to all information in
 TRANSFAC(R) Professional and associated analysis tools including MATCH(TM), a
 powerful new tool used to mine sequences for transcription factor binding
 sites.
     "Adding leading genomics and biotech research groups to Cognia's growing
 list of customers demonstrates that researchers in vastly different areas find
 value in and use our bioinformatics products," said David M. Rubin, Ph.D.,
 Cognia's President and CEO.  Holger Karas, CEO of BIOBASE added, "TRANSFAC(R)
 Professional may help these researchers accelerate their discovery processes
 by helping them understand and navigate more efficiently through their
 research data."
     The information contained in TRANSFAC(R) Professional spans a broad range
 of organisms, including plant, yeast, murine, and human systems.  Also
 included is information from the SNP Consortium enabling users of TRANSFAC(R)
 Professional to more easily use this genetic variance data in their research.
 The TRANSFAC(R) Professional database and associated search tools were created
 and continue to be annotated and curated by BIOBASE of Braunschweig, Germany.
 Cognia Corporation is a developer and distributor of knowledge based products
 that facilitate the use of genomic, proteomic and cellomic/physiological
 information.
 
     About BIOBASE Biological Databases GmbH
     BIOBASE is a world leading creator, annotator, and curator of biological
 databases.  Based in Braunschweig, Germany, BIOBASE develops databases and
 software aimed at analyzing transcription regulation, one of the fundamental
 mechanisms in biology.  BIOBASE is a private company and was established in
 1997 at the National Research Center for Biotechnology Ltd. (GBF).  BIOBASE
 offers worldwide a unique portfolio of databases including the TRANSFAC(R)
 database, the premier database on transcription factors, their genomic binding
 sites, and their general binding properties.
 
     About Cognia
     Cognia is a developer and distributor of knowledge-based products that
 facilitate the use of genomic, proteomic and cellomic/physiological
 information.  Cognia provides integrated suites of high-quality, annotated
 databases, cutting edge bioinformatics tools, and associated consulting and
 training services to accelerate drug discovery and basic research.  Cognia's
 products and services help pharmaceutical and biotechnology companies to
 efficiently and cost-effectively discover and develop new drugs, by
 accelerating research processes.  Cognia's customers include leading
 pharmaceutical and biotechnology companies such as SmithKline Beecham,
 Schering-Plough, Eli Lilly, Monsanto, Protein Pathways, Berlex Biosciences,
 and Scios.
 
 SOURCE  Cognia Corporation